Our Blog
Richard Faris, PharmD, Chief Commercial & Clinical Officer at PANTHERx Rare was a guest on the Pharmacy Podcast Network to new stakeholder feedback data revealing communication gaps in rare disease care.
Pharmacy Profit Summit 2026 + Rare Disease Day 2026 | TWIRx | Pharmacy Podcast Network | March 2, 2026
On this episode of This Week in Pharmacy, we spotlight two major conversations shaping the future of pharmacy practice in 2026. First, we welcome Dr....
Specialty Pharmacy Continuum: As Rare Disease Drug Approvals Accelerate, Survey Highlights Gaps in Care Coordination
Specialty Pharmacy Continuum | March 2, 2026
As the pipeline for rare disease therapies continues to expand, new survey data suggest that the healthcare system is not keeping pace with the coordination...
Celebrating Rare Disease Day at PANTHERx: A Day of Purpose, Connection, and Community
March 2, 2026
https://vimeo.com/1168986887?share=copy&fl=sv&fe=ci Rare Disease Day is more than a date on the calendar at PANTHERx. It’s a moment to pause, reflect, and reconnect with the mission that drives our work every day. Although...
Fierce Healthcare: Survey: Many rare disease patients struggle to navigate care
Fierce Healthcare | February 26, 2026
Communication gaps, preventable delays and limited support place significant responsibility on patients on the rare disease journey, a new survey finds. The survey (PDF) was...
Targeted Reach, Tighter Relationships: Why Rare Disease Launches Are Different
Drug Channels Institute | January 9, 2026
In this Drug Channels Institute guest post, “Targeted Reach, Tighter Relationships: Why Rare Disease Launches Are Different,” PANTHERx’s Chief Commercial & Clinical Officer, Dr. Richard...
PANTHERx Rare Submits Comment Letter for FDA’s Rare Disease Innovation, Science and Exploration (RISE) Workshop Series
January 5, 2026
Dr. Richard Faris, our Chief Commercial and Clinical Officer, recently submitted a proposal on behalf of PANTHERx in response to the FDA’s request for public...
Dr. Richard Faris, Chief Commercial & Clinical Officer at PANTHERx Rare, elected to the Board of Directors for the National Association of Specialty Pharmacy (NASP)
GlobeNewswire | September 16, 2025
Dr. Richard Faris, PhD, MSc, RPh, will bring his extensive expertise to NASP, helping to guide the organization as it advances specialty pharmacy, promotes innovation,...
New article from PANTHERx CEO, Bansi Nagji, explores how hyper-personalization is reshaping the way we approach rare disease care
Drug Channels Institute | September 12, 2025
Bansi explores how the emerging model of “Rare Pharmacy” addresses the challenges rare diseases pose to patients, caregivers, and the healthcare system. His perspective highlights...